title: Improving public health through access to and utilization of medication assisted treatment.
abstract: Providing access to and utilization of medication assisted treatment (MAT) for the treatment of opioid abuse and dependence provides an important opportunity to improve public health. Access to health services comprising MAT in the community is fundamental to achieve broad service coverage. The type and placement of the health services comprising MAT and integration with primary medical care including human immunodeficiency virus (HIV) prevention, care and treatment services are optimal for addressing both substance abuse and co-occurring infectious diseases. As an HIV prevention intervention, integrated (same medical record for HIV services and MAT services) MAT with HIV prevention, care and treatment programs provides the best "one stop shopping" approach for health service utilization. Alternatively, MAT, medical and HIV services can be separately managed but co-located to allow convenient utilization of primary care, MAT and HIV services. A third approach is coordinated care and treatment, where primary care, MAT and HIV services are provided at distinct locations and case managers, peer facilitators, or others promote direct service utilization at the various locations. Developing a continuum of care for patients with opioid dependence throughout the stages MAT enhances the public health and Recovery from opioid dependence. As a stigmatized and medical disenfranchised population with multiple medical, psychological and social needs, people who inject drugs and are opioid dependent have difficulty accessing services and navigating medical systems of coordinated care. MAT programs that offer comprehensive services and medical care options can best contribute to improving the health of these individuals thereby enhancing the health of the community.
authors.affiliation: Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, 1 Choke Cherry Road, Rockville, MD 20857, USA. tkresina@samhsa.gov
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Kresina
authors.forename: Robert
authors.initials: R
authors.lastname: Lubran
mesh_terms: D003695:Delivery of Health Care / Q000706:statistics & numerical data*; D004363:Drug Utilization; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control; D006296:Health Services / Q000706:statistics & numerical data*; D006801:Humans; D008962:Models, Theoretical; D009293:Opioid-Related Disorders / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D011634:Public Health / Q000592:standards*; D014481:United States
references.citation: Curr Opin Psychiatry. 2010 May;23(3):210-4
references.pmid: 20224403
references.citation: Drug Alcohol Depend. 2011 May 1;115(1-2):107-12
references.pmid: 21126831
references.citation: J Urban Health. 2003 Mar;80(1):92-105
references.pmid: 12612099
references.citation: J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1:S32-6
references.pmid: 21045597
references.citation: Drug Alcohol Depend. 2011 Apr 1;114(2-3):233-6
references.pmid: 21075561
references.citation: J Opioid Manag. 2008 Nov-Dec;4(6):369-81
references.pmid: 19192765
references.citation: Drug Alcohol Depend. 1983 Oct;12(2):173-80
references.pmid: 6653389
references.citation: Clin Infect Dis. 2006 Mar 1;42(5):716-21
references.pmid: 16447120
references.citation: Curr Opin Psychiatry. 2009 May;22(3):281-6
references.pmid: 19378380
references.citation: Ann Intern Med. 1997 Oct 1;127(7):526-30
references.pmid: 9313020
references.citation: Subst Abuse. 2008 Apr 28;1:15-61
references.pmid: 25977607
references.citation: CNS Drugs. 2008;22(2):99-111
references.pmid: 18193922
references.citation: Alcohol Clin Exp Res. 2010 Feb;34(2):317-30
references.pmid: 19930235
references.citation: Arch Gen Psychiatry. 2006 Feb;63(2):210-8
references.pmid: 16461865
references.citation: Exp Clin Psychopharmacol. 2008 Oct;16(5):435-41
references.pmid: 18837640
references.citation: J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1:S17-22
references.pmid: 21045594
references.citation: J Subst Abuse Treat. 2006 Dec;31(4):385-93
references.pmid: 17084792
references.citation: J Behav Health Serv Res. 1999 Feb;26(1):80-94
references.pmid: 10069143
references.citation: Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S191-6
references.pmid: 17109306
references.citation: J Addict Med. 2011 Mar;5(1):28-35
references.pmid: 21532972
references.citation: Am J Addict. 2009 Jul-Aug;18(4):289-93
references.pmid: 19444732
references.citation: J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S3-6
references.pmid: 21317591
references.citation: Addiction. 2009 May;104(5):775-83
references.pmid: 19344438
references.citation: JAMA. 2008 Nov 19;300(19):2303-5
references.pmid: 19017918
references.citation: AIDS Care. 2007 Oct;19(9):1128-33
references.pmid: 18058396
references.citation: J Addict Dis. 2010 Apr;29(2):200-16
references.pmid: 20407977
references.citation: Aust N Z J Psychiatry. 1995 Jun;29(2):248-56
references.pmid: 7487787
references.citation: Drug Alcohol Depend. 2011 Apr 1;114(2-3):134-9
references.pmid: 20971585
references.citation: J Subst Abuse Treat. 2003 Oct;25(3):125-34
references.pmid: 14670518
references.citation: J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):493-503
references.pmid: 16652059
references.citation: Curr Psychiatry Rep. 2010 Oct;12(5):448-53
references.pmid: 20640538
references.citation: Addiction. 2001 Jun;96(6):847-60
references.pmid: 11399216
references.citation: Community Ment Health J. 2005 Dec;41(6):757-74
references.pmid: 16328588
references.citation: Psychol Serv. 2010 May;7(2):92-102
references.pmid: 20577571
references.citation: J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1:S37-42
references.pmid: 21045598
references.citation: Infect Dis Clin North Am. 2007 Mar;21(1):149-79, ix
references.pmid: 17502234
references.citation: Am J Addict. 2011 Sep-Oct;20(5):429-34
references.pmid: 21838841
references.citation: Behav Healthc. 2008 May;28(5):8, 13-5
references.pmid: 18561620
references.citation: J Gen Intern Med. 2007 Apr;22(4):527-30
references.pmid: 17372805
references.citation: J Manag Care Pharm. 2010 Feb;16(1 Suppl B):S4-8
references.pmid: 20146548
references.citation: AIDS. 2007 Jan 11;21(2):231-5
references.pmid: 17197815
references.citation: J Behav Health Serv Res. 2007 Apr;34(2):109-20
references.pmid: 17351758
references.citation: Neuropharmacology. 2011 Sep;61(3):421-32
references.pmid: 21466815
references.citation: Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001333
references.pmid: 16437431
references.citation: Drug Alcohol Depend. 2010 Sep 1;111(1-2):166-9
references.pmid: 20570059
references.citation: J Public Health Manag Pract. 1995 Fall;1(4):40-7
references.pmid: 10186640
references.citation: Prog Community Health Partnersh. 2007 Winter;1(4):301-9
references.pmid: 20208210
references.citation: Curr HIV/AIDS Rep. 2010 May;7(2):99-106
references.pmid: 20425564
references.citation: Addict Disord Their Treat. 2010 Mar;9(1):32-40
references.pmid: 20672018
references.citation: Am J Drug Alcohol Abuse. 2007;33(4):527-36
references.pmid: 17668338
references.citation: Psychol Med. 2011 Dec;41(12):2615-23
references.pmid: 21733216
references.citation: Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S247-53
references.pmid: 17109311
references.citation: N Engl J Med. 2002 Sep 12;347(11):817-23
references.pmid: 12226153
references.citation: Ann Intern Med. 2010 Jun 1;152(11):704-11
references.pmid: 20513828
references.citation: Curr Pain Headache Rep. 2010 Feb;14(1):17-21
references.pmid: 20425210